Vitamin C and Derivatives Market Size(US$)

CAGR 2026-2032
4.9%
Market Size,2032
USD 1,978
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Vitamin C and Derivatives was estimated to be worth US$ 1422 million in 2025 and is projected to reach US$ 1978 million, growing at a CAGR of 4.9% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Vitamin C and Derivatives cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Vitamin c not only prevents scurvy but also has a positive effect on skin quality: it helps increase collagen synthesis, provides mild exfoliating benefits and inhibits melanin production. Apart from pure vitamin c, all other derivatives have to be converted into ascorbic acid by the cells in order for the skin to utilize them for collagen production.
The North American market for Vitamin C and Derivatives was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Vitamin C and Derivatives was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Vitamin C and Derivatives was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Vitamin C and Derivatives market include DSM, CSPC Pharma, Shandong Luwei, Northeast Pharma, North China Pharma, Shandong Tianli, Ningxia Qiyuan, Zhengzhou Tuoyang, Henan Huaxing, Jingjiang Hengtong, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Vitamin C and Derivatives, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Vitamin C and Derivatives market size, estimations, and forecasts are presented in terms of sales volume (K MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Vitamin C and Derivatives.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Vitamin C and Derivatives manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Vitamin C and Derivatives sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Vitamin C and Derivatives sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Market Overview
1.1 Vitamin C and Derivatives Product Introduction
1.2 Global Vitamin C and Derivatives Market Size Forecast
1.2.1 Global Vitamin C and Derivatives Sales Value (2021–2032)
1.2.2 Global Vitamin C and Derivatives Sales Volume (2021–2032)
1.2.3 Global Vitamin C and Derivatives Sales Price (2021–2032)
1.3 Vitamin C and Derivatives Market Trends & Drivers
1.3.1 Vitamin C and Derivatives Industry Trends
1.3.2 Vitamin C and Derivatives Market Drivers & Opportunities
1.3.3 Vitamin C and Derivatives Market Challenges
1.3.4 Vitamin C and Derivatives Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Vitamin C and Derivatives Players Revenue Ranking (2025)
2.2 Global Vitamin C and Derivatives Revenue by Company (2021–2026)
2.3 Global Vitamin C and Derivatives Sales Volume Ranking of Players (2025)
2.4 Global Vitamin C and Derivatives Sales Volume by Company (2021–2026)
2.5 Global Vitamin C and Derivatives Average Price by Company (2021–2026)
2.6 Key Manufacturers Vitamin C and Derivatives Manufacturing Base and Headquarters
2.7 Key Manufacturers Vitamin C and Derivatives Product Offerings
2.8 Key Manufacturers Start of Mass Production of Vitamin C and Derivatives
2.9 Vitamin C and Derivatives Market Competitive Analysis
2.9.1 Vitamin C and Derivatives Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Vitamin C and Derivatives Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Vitamin C and Derivatives revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Vitamin C and Derivatives Market Classification
3.1 Introduction by Type
3.1.1 Food Grade
3.1.2 Pharmaceutical Grade
3.1.3 Feed Grade
3.1.4 Global Vitamin C and Derivatives Sales Value by Type
3.1.4.1 Global Vitamin C and Derivatives Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Vitamin C and Derivatives Sales Value, by Type (2021–2032)
3.1.4.3 Global Vitamin C and Derivatives Sales Value, by Type (%), 2021–2032
3.1.5 Global Vitamin C and Derivatives Sales Volume by Type
3.1.5.1 Global Vitamin C and Derivatives Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Vitamin C and Derivatives Sales Volume, by Type (2021–2032)
3.1.5.3 Global Vitamin C and Derivatives Sales Volume, by Type (%), 2021–2032
3.1.6 Global Vitamin C and Derivatives Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food & Beverage
4.1.2 Pharmaceuticals & Healthcare
4.1.3 Feed
4.1.4 Cosmetics
4.1.5 Others
4.2 Global Vitamin C and Derivatives Sales Value by Application
4.2.1 Global Vitamin C and Derivatives Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Vitamin C and Derivatives Sales Value, by Application (2021–2032)
4.2.3 Global Vitamin C and Derivatives Sales Value, by Application (%), 2021–2032
4.3 Global Vitamin C and Derivatives Sales Volume by Application
4.3.1 Global Vitamin C and Derivatives Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Vitamin C and Derivatives Sales Volume, by Application (2021–2032)
4.3.3 Global Vitamin C and Derivatives Sales Volume, by Application (%), 2021–2032
4.4 Global Vitamin C and Derivatives Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Vitamin C and Derivatives Sales Value by Region
5.1.1 Global Vitamin C and Derivatives Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Vitamin C and Derivatives Sales Value by Region (2021–2026)
5.1.3 Global Vitamin C and Derivatives Sales Value by Region (2027–2032)
5.1.4 Global Vitamin C and Derivatives Sales Value by Region (%), 2021–2032
5.2 Global Vitamin C and Derivatives Sales Volume by Region
5.2.1 Global Vitamin C and Derivatives Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Vitamin C and Derivatives Sales Volume by Region (2021–2026)
5.2.3 Global Vitamin C and Derivatives Sales Volume by Region (2027–2032)
5.2.4 Global Vitamin C and Derivatives Sales Volume by Region (%), 2021–2032
5.3 Global Vitamin C and Derivatives Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Vitamin C and Derivatives Sales Value, 2021–2032
5.4.2 North America Vitamin C and Derivatives Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Vitamin C and Derivatives Sales Value, 2021–2032
5.5.2 Europe Vitamin C and Derivatives Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Vitamin C and Derivatives Sales Value, 2021–2032
5.6.2 Asia Pacific Vitamin C and Derivatives Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Vitamin C and Derivatives Sales Value, 2021–2032
5.7.2 South America Vitamin C and Derivatives Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Vitamin C and Derivatives Sales Value, 2021–2032
5.8.2 Middle East & Africa Vitamin C and Derivatives Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Vitamin C and Derivatives Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Vitamin C and Derivatives Sales Value and Sales Volume
6.2.1 Key Countries/Regions Vitamin C and Derivatives Sales Value, 2021–2032
6.2.2 Key Countries/Regions Vitamin C and Derivatives Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Vitamin C and Derivatives Sales Value, 2021–2032
6.3.2 United States Vitamin C and Derivatives Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Vitamin C and Derivatives Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Vitamin C and Derivatives Sales Value, 2021–2032
6.4.2 Europe Vitamin C and Derivatives Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Vitamin C and Derivatives Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Vitamin C and Derivatives Sales Value, 2021–2032
6.5.2 China Vitamin C and Derivatives Sales Value by Type (%), 2025 vs 2032
6.5.3 China Vitamin C and Derivatives Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Vitamin C and Derivatives Sales Value, 2021–2032
6.6.2 Japan Vitamin C and Derivatives Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Vitamin C and Derivatives Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Vitamin C and Derivatives Sales Value, 2021–2032
6.7.2 South Korea Vitamin C and Derivatives Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Vitamin C and Derivatives Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Vitamin C and Derivatives Sales Value, 2021–2032
6.8.2 Southeast Asia Vitamin C and Derivatives Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Vitamin C and Derivatives Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Vitamin C and Derivatives Sales Value, 2021–2032
6.9.2 India Vitamin C and Derivatives Sales Value by Type (%), 2025 vs 2032
6.9.3 India Vitamin C and Derivatives Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 DSM
7.1.1 DSM Company Information
7.1.2 DSM Introduction and Business Overview
7.1.3 DSM Vitamin C and Derivatives Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 DSM Vitamin C and Derivatives Product Offerings
7.1.5 DSM Recent Developments
7.2 CSPC Pharma
7.2.1 CSPC Pharma Company Information
7.2.2 CSPC Pharma Introduction and Business Overview
7.2.3 CSPC Pharma Vitamin C and Derivatives Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 CSPC Pharma Vitamin C and Derivatives Product Offerings
7.2.5 CSPC Pharma Recent Developments
7.3 Shandong Luwei
7.3.1 Shandong Luwei Company Information
7.3.2 Shandong Luwei Introduction and Business Overview
7.3.3 Shandong Luwei Vitamin C and Derivatives Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Shandong Luwei Vitamin C and Derivatives Product Offerings
7.3.5 Shandong Luwei Recent Developments
7.4 Northeast Pharma
7.4.1 Northeast Pharma Company Information
7.4.2 Northeast Pharma Introduction and Business Overview
7.4.3 Northeast Pharma Vitamin C and Derivatives Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Northeast Pharma Vitamin C and Derivatives Product Offerings
7.4.5 Northeast Pharma Recent Developments
7.5 North China Pharma
7.5.1 North China Pharma Company Information
7.5.2 North China Pharma Introduction and Business Overview
7.5.3 North China Pharma Vitamin C and Derivatives Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 North China Pharma Vitamin C and Derivatives Product Offerings
7.5.5 North China Pharma Recent Developments
7.6 Shandong Tianli
7.6.1 Shandong Tianli Company Information
7.6.2 Shandong Tianli Introduction and Business Overview
7.6.3 Shandong Tianli Vitamin C and Derivatives Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Shandong Tianli Vitamin C and Derivatives Product Offerings
7.6.5 Shandong Tianli Recent Developments
7.7 Ningxia Qiyuan
7.7.1 Ningxia Qiyuan Company Information
7.7.2 Ningxia Qiyuan Introduction and Business Overview
7.7.3 Ningxia Qiyuan Vitamin C and Derivatives Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Ningxia Qiyuan Vitamin C and Derivatives Product Offerings
7.7.5 Ningxia Qiyuan Recent Developments
7.8 Zhengzhou Tuoyang
7.8.1 Zhengzhou Tuoyang Company Information
7.8.2 Zhengzhou Tuoyang Introduction and Business Overview
7.8.3 Zhengzhou Tuoyang Vitamin C and Derivatives Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Zhengzhou Tuoyang Vitamin C and Derivatives Product Offerings
7.8.5 Zhengzhou Tuoyang Recent Developments
7.9 Henan Huaxing
7.9.1 Henan Huaxing Company Information
7.9.2 Henan Huaxing Introduction and Business Overview
7.9.3 Henan Huaxing Vitamin C and Derivatives Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Henan Huaxing Vitamin C and Derivatives Product Offerings
7.9.5 Henan Huaxing Recent Developments
7.10 Jingjiang Hengtong
7.10.1 Jingjiang Hengtong Company Information
7.10.2 Jingjiang Hengtong Introduction and Business Overview
7.10.3 Jingjiang Hengtong Vitamin C and Derivatives Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Jingjiang Hengtong Vitamin C and Derivatives Product Offerings
7.10.5 Jingjiang Hengtong Recent Developments
7.11 Henan Xinxiang Huaxing
7.11.1 Henan Xinxiang Huaxing Company Information
7.11.2 Henan Xinxiang Huaxing Introduction and Business Overview
7.11.3 Henan Xinxiang Huaxing Vitamin C and Derivatives Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Henan Xinxiang Huaxing Vitamin C and Derivatives Product Offerings
7.11.5 Henan Xinxiang Huaxing Recent Developments
8 Industry Chain Analysis
8.1 Vitamin C and Derivatives Industrial Chain
8.2 Vitamin C and Derivatives Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Vitamin C and Derivatives Sales Model
8.5.2 Sales Channels
8.5.3 Vitamin C and Derivatives Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
List of Figures
Related Reports
Vitamin c not only prevents scurvy but also has a positive effect on skin quality: it helps increase collagen synthesis, provides mild exfoliating benefits and inhibits melanin production. Apart from pure vitamin c, all other derivatives have to be converted into ascorbic acid by the cells in order for the skin to utilize them for collagen production.
Published Date: 2024-01-31
Pages: 104
USD 2900.00
(Single User License)
Vitamin c not only prevents scurvy but also has a positive effect on skin quality: it helps increase collagen synthesis, provides mild exfoliating benefits and inhibits melanin production. Apart from pure vitamin c, all other derivatives have to be converted into ascorbic acid by the cells in order for the skin to utilize them for collagen production.
Published Date: 2024-04-06
Pages: 113
USD 4900.00
(Single User License)
The global market for Vitamin C and Derivatives was valued at US$ 1362 million in the year 2024 and is projected to reach a revised size of US$ 1894 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published Date: 2025-02-20
Pages: 102
USD 2900.00
(Single User License)
The global market for Vitamin C and Derivatives was estimated to be worth US$ 1362 million in 2024 and is forecast to a readjusted size of US$ 1894 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 112
USD 3950.00
(Single User License)
The global Vitamin C and Derivatives market size was US$ 1362 million in 2024 and is forecast to a readjusted size of US$ 1894 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 96
USD 4250.00
(Single User License)
The global Vitamin C and Derivatives market is projected to grow from US$ 1362 million in 2024 to US$ 1894 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-24
Pages: 170
USD 4900.00
(Single User License)
The global Vitamin C and Derivatives market was valued at US$ 1422 million in 2025 and is anticipated to reach US$ 1978 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published Date: 2026-04-21
Pages: 137
USD 2900.00
(Single User License)
Vitamin c not only prevents scurvy but also has a positive effect on skin quality: it helps increase collagen synthesis, provides mild exfoliating benefits and inhibits melanin production. Apart from pure vitamin c, all other derivatives have to be converted into ascorbic acid by the cells in order for the skin to utilize them for collagen production.
Published: 2024-01-31
Pages: 104
Vitamin c not only prevents scurvy but also has a positive effect on skin quality: it helps increase collagen synthesis, provides mild exfoliating benefits and inhibits melanin production. Apart from pure vitamin c, all other derivatives have to be converted into ascorbic acid by the cells in order for the skin to utilize them for collagen production.
Published: 2024-04-06
Pages: 113
The global market for Vitamin C and Derivatives was valued at US$ 1362 million in the year 2024 and is projected to reach a revised size of US$ 1894 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published: 2025-02-20
Pages: 102
The global market for Vitamin C and Derivatives was estimated to be worth US$ 1362 million in 2024 and is forecast to a readjusted size of US$ 1894 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 112
The global Vitamin C and Derivatives market size was US$ 1362 million in 2024 and is forecast to a readjusted size of US$ 1894 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 96
The global Vitamin C and Derivatives market is projected to grow from US$ 1362 million in 2024 to US$ 1894 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-24
Pages: 170
The global Vitamin C and Derivatives market was valued at US$ 1422 million in 2025 and is anticipated to reach US$ 1978 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-04-21
Pages: 137
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research